VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EBMT 2020 | Cellular therapies: from academia to industry

Jürgen Kuball • 30 Aug 2020
EBMT 2020
General CAR-T

Jürgen Kuball, MD, PhD, Utrecht University, Utrecht University, Netherlands, discusses how cellular therapies are translated from academia to industrial partners and the challenges associated with this. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

More from Jürgen Kuball

1:31
Gamma delta T-cell therapy
Jürgen Kuball • 1 Sep 2020
2:41
CAR-T19: A novel model of recognition
Jürgen Kuball
0:44
CAR T-cell therapy for solid cancers
Jürgen Kuball
1:22
Sharing CAR T-cell data: an EBMT perspective
Jürgen Kuball

Related Videos

2:25
Focus of the ASTCT in 2021 and beyond
Pavan Reddy • 24 Feb 2021
3:16
ASTCT response to the COVID-19 pandemic
Pavan Reddy • 24 Feb 2021
4:23
TCT 2021: oxygen sensing, pediatric CAR-T & the microbiome
Pavan Reddy • 24 Feb 2021
3:55
Highlights from TCT 2021
Pavan Reddy • 24 Feb 2021
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJHemOnc is intended for healthcare professionals